\-\ Texto\\:\\ \ \(0\)\
\-\ no\\ metabolic\\ abnormality\\.\ \(0\)\
\-\ resection\\,\\ if\\ complete\\,\\ is\\ usually\\ sufficient\\.\\ \\ it\\ has\\ not\\ yet\\ been\\ decided\\ if\\ this\\ patient\\ will\\ undergo\\ additional\\ tx\\.\ \(0\)\
\-\ large\\,\\ solid\\ mass\\ in\\ the\\ left\\ cerebellar\\ hemisphere\\ with\\ ill\\-defined\\ margins\\ and\\ significant\\ surrounding\\ t2\\ signal\\ abnormality\\ representing\\ vasogenic\\ edema\\.\\ \\ this\\ exerts\\ mass\\ effect\\ upon\\ and\\ displaces\\ the\\ 4th\\ ventricle\\.\\ \\ mild\\ hydrocephalus\\.\\ \\ diffuse\\,\\ heterogeneous\\ enhancement\\ following\\ iv\\ gadolinium\\ infusion\\.\\ \\ ct\\ scan\\ demonstrates\\ a\\ notably\\ low\\ attenuation\\ mass\\,\\ and\\ inferior\\ displacement\\ of\\ the\\ cerebellar\\ tonsils\\ to\\ the\\ level\\ of\\ the\\ foramen\\ magnum\\.\ \(0\)\
\-\ pilocytic\\ astrocytoma\ \(31\)\
\-\ \\<li\\>astrocytoma\\ \\(pilocytic\\ or\\ fibrillary\\)\ \(0\)\
\-\ \\<li\\>ependymoma\ \(0\)\
\-\ \\<li\\>medulloblastoma\ \(0\)\
\-\ his\\ mother\\ provides\\ a\\ history\\ of\\ increasing\\ headaches\\ over\\ past\\ month\\,\\ gait\\ disturbances\\,\\ and\\ possible\\ seizure\\ activity\\.\ \(0\)\
\-\ the\\ mass\\ arises\\ from\\ the\\ left\\ cerebellar\\ hemisphere\\ and\\ not\\ the\\ 4th\\ ventricle\\,\\ and\\ is\\ hypodense\\ on\\ ct\\.\\ \\ these\\ findings\\ make\\ medulloblastoma\\ far\\ less\\ likely\\.\\ \\ a\\ mass\\ entirely\\ outside\\ the\\ ventricle\\ makes\\ ependyoma\\ less\\ likely\\.\\ \\ while\\ pilocytic\\ astrocytomas\\ \\(pa\\)\\ are\\ usually\\ cystic\\ with\\ an\\ enhancing\\ mural\\ nodule\\,\\ this\\ case\\ represents\\ the\\ less\\ common\\ solid\\ variant\\.\\ \\ approximately\\ 85\\%\\ of\\ posterior\\ fossa\\ astrocytomas\\ in\\ childhood\\ are\\ pilocytic\\ \\-\\ the\\ remainder\\ are\\ fibrillary\\-diffuse\\.\\ \\ pilocytic\\ astrocytomas\\ are\\ who\\ grade\\ 1\\;\\ whereas\\ fibrillary\\ may\\ be\\ grade\\ 2\\-4\\.\\ enhancement\\ in\\ pa\\ is\\ almost\\ universal\\.\\ \\ enhancement\\ in\\ diffuse\\ astrocytoma\\ is\\ associated\\ with\\ vascular\\ changes\\ and\\ a\\ higher\\ tumor\\ grade\\ \\-\\ either\\ grade\\ 3\\ or\\ grade\\ 4\\.\ \(0\)\
\-\ click\\ here\\ to\\ see\\ other\\ pilocytic\\ astrocytomas\\:\ \(0\)\
\-\ http\\:\\/\\/rad\\.usuhs\\.mil\\/medpix\\/medpix\\.html\\?mode\\=image\\_finder\\&action\\=search\\&srchstr\\=pilocytic\\%20astrocytoma\\&srch\\_type\\=all\\#top\ \(1\)\
\-\ click\\ here\\ to\\ see\\ medulloblastoma\\:\ \(0\)\
\-\ http\\:\\/\\/rad\\.usuhs\\.mil\\/medpix\\/medpix\\.html\\?mode\\=image\\_finder\\&action\\=search\\&srchstr\\=medulloblastoma\\&srch\\_type\\=all\\#top\ \(1\)\
\-\ click\\ here\\ to\\ see\\ ependymoma\\:\ \(0\)\
\-\ http\\:\\/\\/rad\\.usuhs\\.mil\\/medpix\\/medpix\\.html\\?mode\\=image\\_finder\\&action\\=search\\&srchstr\\=ependymoma\\&srch\\_type\\=all\\#top\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\&\\:\\ 0\\.08521290545511952\ \(0\)\
\-\ pilocytic\\:\\ 0\\.08513622038669126\ \(0\)\
\-\ astrocytomas\\:\\ 0\\.07476525761602945\ \(0\)\
\-\ action\\=search\\:\\ 0\\.06374836166201889\ \(0\)\
\-\ mode\\=image\\_finder\\:\\ 0\\.059153650471655786\ \(0\)\
\-\ srch\\_type\\=all\\:\\ 0\\.05845231319575306\ \(0\)\
\-\ \\/\\/rad\\.usuhs\\.mil\\/medpix\\/medpix\\.html\\:\\ 0\\.05607394321202209\ \(0\)\
\-\ click\\:\\ 0\\.05417485145685977\ \(0\)\
\-\ grade\\:\\ 0\\.0513381197626336\ \(0\)\
\-\ medulloblastoma\\:\\ 0\\.04699089106236379\ \(0\)\
\-\ fibrillary\\:\\ 0\\.04546423035667128\ \(0\)\
\-\ top\\:\\ 0\\.04335721059339973\ \(0\)\
\-\ li\\:\\ 0\\.04308680012862949\ \(0\)\
\-\ here\\:\\ 0\\.04219693625183193\ \(0\)\
\-\ cerebellar\\:\\ 0\\.03487968178905449\ \(0\)\
\-\ \\#\\:\\ 0\\.031719431724992635\ \(0\)\
\-\ \\?\\:\\ 0\\.03156037382294486\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.03140394509785454\ \(0\)\
\-\ \\<\\:\\ 0\\.031211976600963316\ \(0\)\
\-\ http\\:\\ 0\\.030622605028204505\ \(0\)\
\-\ ventricle\\:\\ 0\\.03030653297392834\ \(0\)\
\-\ ependyoma\\:\\ 0\\.02780920638475236\ \(0\)\
\-\ fibrillary\\-diffuse\\:\\ 0\\.02780920638475236\ \(0\)\
\-\ 2\\-4\\.\\:\\ 0\\.02780920638475236\ \(0\)\
\-\ srchstr\\=pilocytic\\:\\ 0\\.02780920638475236\ \(0\)\
\-\ 20astrocytoma\\:\\ 0\\.02780920638475236\ \(0\)\
\-\ srchstr\\=medulloblastoma\\:\\ 0\\.02780920638475236\ \(0\)\
\-\ srchstr\\=ependymoma\\:\\ 0\\.02780920638475236\ \(0\)\
\-\ hemisphere\\:\\ 0\\.02744233631111618\ \(0\)\
\-\ less\\:\\ 0\\.02738744483586135\ \(0\)\
\-\ 4th\\:\\ 0\\.02715873134037633\ \(0\)\
\-\ \\>\\:\\ 0\\.02686909319875613\ \(0\)\
\-\ universal\\:\\ 0\\.025622622218948114\ \(0\)\
\-\ see\\:\\ 0\\.024134547740335535\ \(0\)\
\-\ ependymoma\\:\\ 0\\.024133033673108907\ \(0\)\
\-\ pa\\:\\ 0\\.022547453683954926\ \(0\)\
\-\ enhancement\\:\\ 0\\.021676549837126524\ \(0\)\
\-\ exerts\\:\\ 0\\.021670688564388595\ \(0\)\
\-\ solid\\:\\ 0\\.021503764369125423\ \(0\)\
\-\ \\:\\:\\ 0\\.02139321418278861\ \(0\)\
\-\ abnormality\\:\\ 0\\.01988995548158077\ \(0\)\
\-\ notably\\:\\ 0\\.019062869721535383\ \(0\)\
\-\ mass\\:\\ 0\\.018745441749961584\ \(0\)\
\-\ infusion\\:\\ 0\\.01765502397191892\ \(0\)\
\-\ disturbances\\:\\ 0\\.01765502397191892\ \(0\)\
\-\ decided\\:\\ 0\\.017531299324747684\ \(0\)\
\-\ magnum\\:\\ 0\\.017297520232780108\ \(0\)\
\-\ tonsils\\:\\ 0\\.01697643917817461\ \(0\)\
\-\ sufficient\\:\\ 0\\.016779214077287122\ \(0\)\
\-\ displaces\\:\\ 0\\.016779214077287122\ \(0\)\
\-\ tx\\:\\ 0\\.016685040691956896\ \(0\)\
\-\ provides\\:\\ 0\\.016685040691956896\ \(0\)\
\-\ entirely\\:\\ 0\\.01650473023820312\ \(0\)\
\-\ usually\\:\\ 0\\.016371787090642013\ \(0\)\
\-\ diffuse\\:\\ 0\\.01632181337776224\ \(0\)\
\-\ arises\\:\\ 0\\.016172362680922907\ \(0\)\
\-\ whereas\\:\\ 0\\.016018450491113972\ \(0\)\
\-\ mural\\:\\ 0\\.015344715158943438\ \(0\)\
\-\ ill\\-defined\\:\\ 0\\.015225660496536984\ \(0\)\
\-\ far\\:\\ 0\\.015225660496536984\ \(0\)\
\-\ likely\\:\\ 0\\.015206876756691839\ \(0\)\
\-\ childhood\\:\\ 0\\.01516777677834078\ \(0\)\
\-\ yet\\:\\ 0\\.015110936066975863\ \(0\)\
\-\ 85\\:\\ 0\\.015055101438902044\ \(0\)\
\-\ makes\\:\\ 0\\.014946312239939365\ \(0\)\
\-\ are\\:\\ 0\\.014698723943591188\ \(0\)\
\-\ if\\:\\ 0\\.014629296112180664\ \(0\)\
\-\ vasogenic\\:\\ 0\\.014592629911482878\ \(0\)\
\-\ make\\:\\ 0\\.01440701319216763\ \(0\)\
\-\ hypodense\\:\\ 0\\.014362266709543162\ \(0\)\
\-\ representing\\:\\ 0\\.013907883838177428\ \(0\)\
\-\ undergo\\:\\ 0\\.013685115487344768\ \(0\)\
\-\ metabolic\\:\\ 0\\.013313560169816746\ \(0\)\
\-\ higher\\:\\ 0\\.013219386784486519\ \(0\)\
\-\ almost\\:\\ 0\\.013039076330732738\ \(0\)\
\-\ represents\\:\\ 0\\.012952644235502096\ \(0\)\
\-\ foramen\\:\\ 0\\.012868517273097799\ \(0\)\
\-\ variant\\:\\ 0\\.012840966232186902\ \(0\)\
\-\ gadolinium\\:\\ 0\\.012786575675611173\ \(0\)\
\-\ remainder\\:\\ 0\\.012706708773452532\ \(0\)\
\-\ \\%\\:\\ 0\\.012576157939091531\ \(0\)\
\-\ gait\\:\\ 0\\.012552796583643597\ \(0\)\
\-\ mother\\:\\ 0\\.01231187236034841\ \(0\)\
\-\ margins\\:\\ 0\\.012243042557841661\ \(0\)\
\-\ seizure\\:\\ 0\\.011919765998589493\ \(0\)\
\-\ either\\:\\ 0\\.011740593763910838\ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.011589447531431665\ \(0\)\
\-\ \\-\\:\\ 0\\.011556646427182104\ \(0\)\
\-\ displacement\\:\\ 0\\.011552766023560628\ \(0\)\
\-\ outside\\:\\ 0\\.011307286457766281\ \(0\)\
\-\ nodule\\:\\ 0\\.011111083909280776\ \(0\)\
\-\ increasing\\:\\ 0\\.011048304242664703\ \(0\)\
\-\ upon\\:\\ 0\\.011017376797564952\ \(0\)\
\-\ fossa\\:\\ 0\\.010986749623662867\ \(0\)\
\-\ attenuation\\:\\ 0\\.010837921357810847\ \(0\)\
\-\ additional\\:\\ 0\\.010808980107728699\ \(0\)\
\-\ 4\\.\\:\\ 0\\.010613501483914187\ \(0\)\
\-\ headaches\\:\\ 0\\.010304234508111288\ \(0\)\
\-\ activity\\:\\ 0\\.010113711762717787\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.009912287560867525\ \(0\)\
\-\ iv\\:\\ 0\\.009837302641833103\ \(0\)\
\-\ effect\\:\\ 0\\.009544347801480267\ \(0\)\
\-\ complete\\:\\ 0\\.009486990328031717\ \(0\)\
\-\ inferior\\:\\ 0\\.009146108395454457\ \(0\)\
\-\ this\\:\\ 0\\.009095935772688956\ \(0\)\
\-\ possible\\:\\ 0\\.00907880826146395\ \(0\)\
\-\ surrounding\\:\\ 0\\.008861720076860459\ \(0\)\
\-\ vascular\\:\\ 0\\.008838496113323964\ \(0\)\
\-\ past\\:\\ 0\\.008565298018758468\ \(0\)\
\-\ while\\:\\ 0\\.008481543343382691\ \(0\)\
\-\ enhancing\\:\\ 0\\.008454112091119114\ \(0\)\
\-\ will\\:\\ 0\\.008433694064287513\ \(0\)\
\-\ resection\\:\\ 0\\.008406673992177345\ \(0\)\
\-\ approximately\\:\\ 0\\.008340119326673763\ \(0\)\
\-\ month\\:\\ 0\\.00808711211609025\ \(0\)\
\-\ not\\:\\ 0\\.007790654080390759\ \(0\)\
\-\ cystic\\:\\ 0\\.007774866584390405\ \(0\)\
\-\ level\\:\\ 0\\.007769366017813665\ \(0\)\
\-\ his\\:\\ 0\\.007769366017813665\ \(0\)\
\-\ changes\\:\\ 0\\.007725703395063282\ \(0\)\
\-\ \\,\\:\\ 0\\.0076857747307747205\ \(0\)\
\-\ following\\:\\ 0\\.007650718476028859\ \(0\)\
\-\ t2\\:\\ 0\\.007629617567035811\ \(0\)\
\-\ edema\\:\\ 0\\.007624364319972526\ \(0\)\
\-\ scan\\:\\ 0\\.007546597666981005\ \(0\)\
\-\ ct\\:\\ 0\\.007541347970927715\ \(0\)\
\-\ low\\:\\ 0\\.0074957982740264965\ \(0\)\
\-\ been\\:\\ 0\\.007333737821652969\ \(0\)\
\-\ significant\\:\\ 0\\.007248729183136351\ \(0\)\
\-\ signal\\:\\ 0\\.0071074900008605\ \(0\)\
\-\ mild\\:\\ 0\\.007098591337322198\ \(0\)\
\-\ is\\:\\ 0\\.0070951517777252445\ \(0\)\
\-\ common\\:\\ 0\\.007054470700177909\ \(0\)\
\-\ who\\:\\ 0\\.0070282915114880185\ \(0\)\
\-\ these\\:\\ 0\\.007015282939930095\ \(0\)\
\-\ over\\:\\ 0\\.006863225836403667\ \(0\)\
\-\ 1\\:\\ 0\\.006414278763279832\ \(0\)\
\-\ \\;\\:\\ 0\\.006389341288493986\ \(0\)\
\-\ associated\\:\\ 0\\.006361080636932814\ \(0\)\
\-\ or\\:\\ 0\\.0063187555139666085\ \(0\)\
\-\ 3\\:\\ 0\\.006312225636298232\ \(0\)\
\-\ tumor\\:\\ 0\\.006284644484576691\ \(0\)\
\-\ posterior\\:\\ 0\\.006213370816096052\ \(0\)\
\-\ other\\:\\ 0\\.006213370816096052\ \(0\)\
\-\ it\\:\\ 0\\.006059458626287119\ \(0\)\
\-\ left\\:\\ 0\\.006032209900775487\ \(0\)\
\-\ may\\:\\ 0\\.005912707788322157\ \(0\)\
\-\ case\\:\\ 0\\.005897490324502431\ \(0\)\
\-\ large\\:\\ 0\\.0058944556209182325\ \(0\)\
\-\ demonstrates\\:\\ 0\\.005888394957896486\ \(0\)\
\-\ findings\\:\\ 0\\.005737655948864225\ \(0\)\
\-\ to\\:\\ 0\\.005388872030826325\ \(0\)\
\-\ in\\:\\ 0\\.005317315206817097\ \(0\)\
\-\ has\\:\\ 0\\.005062145017332107\ \(0\)\
\-\ a\\:\\ 0\\.005004413903073833\ \(0\)\
\-\ the\\:\\ 0\\.004797293790977551\ \(0\)\
\-\ \\(\\:\\ 0\\.004557487231822464\ \(0\)\
\-\ \\)\\:\\ 0\\.0045018150921975085\ \(0\)\
\-\ be\\:\\ 0\\.0041569612723783254\ \(0\)\
\-\ from\\:\\ 0\\.0039950653411804805\ \(0\)\
\-\ and\\:\\ 0\\.003974962271689367\ \(0\)\
\-\ an\\:\\ 0\\.0037276494141474125\ \(0\)\
\-\ history\\:\\ 0\\.003723074251441903\ \(0\)\
\-\ no\\:\\ 0\\.0027143348602643594\ \(0\)\
\-\ patient\\:\\ 0\\.002702182747370309\ \(0\)\
\-\ on\\:\\ 0\\.002283567862351508\ \(0\)\
\-\ \\.\\:\\ 0\\.0016797887743223788\ \(0\)\
\-\ of\\:\\ 0\\.0014700795053373935\ \(0\)\
\-\ with\\:\\ 0\\.0011072950418601552\ \(0\)\
